Phio Pharmaceuticals
PHIO
#10277
Rank
NZ$21.28 M
Marketcap
NZ$1.93
Share price
-1.75%
Change (1 day)
-61.24%
Change (1 year)

Earnings for Phio Pharmaceuticals (PHIO)

Earnings in 2025 (TTM): -NZ$11.96 Million

According to Phio Pharmaceuticals's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -NZ$12.31 Million, an increase over its 2023 earnings that were of -NZ$18.64 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Phio Pharmaceuticals from 2011 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -NZ$11.96 Million-2.83%
2024 -NZ$12.31 Million-33.96%
2023 -NZ$18.64 Million-5.7%
2022 -NZ$19.77 Million-13.6%
2021 -NZ$22.88 Million51.09%
2020 -NZ$15.14 Million-1.28%
2019 -NZ$15.34 Million21.03%
2018 -NZ$12.67 Million-53.1%
2017 -NZ$27.02 Million74.49%
2016 -NZ$15.49 Million-12.02%
2015 -NZ$17.6 Million16.17%
2014 -NZ$15.15 Million-57.95%
2013 -NZ$36.03 Million62.45%
2012 -NZ$22.18 Million0.87%
2011 -NZ$21.99 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Onconova Therapeutics
ONTX
-NZ$31.26 Million 156.26%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
-NZ$0.28 Billion 2,150.94%๐Ÿ‡บ๐Ÿ‡ธ USA